Buscar
Mostrando ítems 1-10 de 134
Vaccines in leishmaniasis: advances in the last five years
(Future Drugs LTD, 2014)
American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline.
(The International Society of Dermatology, 2014)
Advances in Development of New Treatment for Leishmaniasis.
(Hindawi Publishing Corporation, 2016)
Activity of antimalarial drugs in vitro and in a murine model of cutaneous leishmaniasis
(Society for General Microbiology, 2014)
Atividade antileishmania do fulerol e efeito hepatoprotetor na quimioterapia antimonial em modelo murino de leishmaniose visceral
(Universidade Federal de Minas GeraisUFMG, 2014-12-09)
Due to the limitations of the actual treatment of leishmaniasis using pentavalent antimonials, such as glucantime, a first aim of this study was to evaluate the impact of fullerol, which is a spherical water-soluble carbon ...
Avaliação do potencial terapêutico do 17-AAG na infecção in vitro por Leishmania infantum
(Universidade Federal de Sergipe - Pró-Reitoria de Pós-Graduação e Pesquisa - Coordenação de Pesquisa, 2019)